Waddell & Associates’s Incyte INCY Stock Holding History
Bought
Maintained
Sold
Other funds holding INCY
AT
GC
SAM
CGH
CAMG
PAMG
Waddell & Associates's INCY Position: Q2 2026 in Review
Waddell & Associates increased its Incyte (INCY) stake by 7.8% in Q2 2026, buying an estimated $75.3K and bringing the position to 10,470 shares worth $1.19M. The position accounts for 0.06% of the portfolio, ranked #115.
Waddell & Associates first reported a position in INCY in Q2 2025 and has held it in 5 quarters since. 142 funds tracked by Wall St. Rank hold INCY as of Q2 2026.
- Waddell & Associates held 10,470 shares of Incyte worth $1.19M as of Q2 2026.
- Waddell & Associates bought 759 Incyte shares in Q2 2026, an estimated $75.3K.
- Incyte made up 0.06% of Waddell & Associates's portfolio in Q2 2026, its #115 holding.
- Waddell & Associates first reported a position in Incyte in Q2 2025 and has held it in 5 quarters since.
- 142 funds tracked by Wall St. Rank held Incyte as of Q2 2026.
Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.